BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans

Human Gene Therapy

Volumn 18, Issue 1, 2007, Pages 10-17

  Noguchi, Hirofumi ^a,b,c   Ueda, Michiko ^a,c,d   Matsumoto, Shinichi ^a,d   Kobayashi, Naoya ^e   Hayashi, Shuji ^a,b  

^a Diabetes Research Institute Japan   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL SURFACE PROTEIN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; CHONDROITIN ABC LYASE; DERMATAN SULFATE; DEXTRAN SULFATE; GLUCAGON; GLYCOSAMINOGLYCAN; HEPARIN; HEPARIN LYASE; INSULIN; LYSINE; NEUROGENIC DIFFERENTIATION FACTOR; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MUTANT; CELL TYPE; CHO CELL; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSCRIPTION; GLYCOSAMINOGLYCAN METABOLISM; INTERNALIZATION; NONHUMAN; PANCREAS ISLET CELL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SULFATION; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CATTLE; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INSULIN; PROTEIN TRANSPORT; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC;

EID: 33846239386     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.118     Document Type: Article

References (31)

1. BANG, A.G., and GOULDING, M.D. (1996). Regulation of vertebrate neural cell fate by transcription factors. Curr. Opin. Neurobiol. 6, 25-32.
2. ELLIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
3. ESKO, J.D., STEWART, T.E., and TAYLOR, W.H. (1985). Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 82, 3197-3201.
4. ESKO, J.D., ELGAVISH, A., PRASTHOFER, T., TAYLOR, W.H., and WEINKE, J.L. (1986). Sulfate transport-deficient mutants of Chinese hamster ovary cells: Sulfation of glycosaminoglycans dependent on cysteine. J. Biol. Chem. 261, 15725-15733.
5. ESKO, J.D., WEINKE, J.L., TAYLOR, W.H., EKBORG, G., RODEN, L., ANANTHARAMAIAH, G., and GAWISH, A. (1987). Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J. Biol. Chem. 262, 12189-12195.
6. GLICK, E., LESHKOWITZ, D., and WALKER, M.D. (2000). Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J. Biol. Chem. 275, 2199-2204.
7. JOLIOT, A., and PROCHIANTZ, A. (2004). Transduction peptides: From technology to physiology. Nat. Cell Biol. 6, 189-196.
8. JONAS, J.C., SHARMA, A., HASENKAMP, W., ILKOVA, H., PATANE, G., LAYBUTT, R., BONNER-WEIR, S., and WEIR, G.C. (1999). Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem. 274, 14112-14121.
9. JONSSON, J., CARLSSON, L., EDLUND, T., and EDLUND, H. (1994). Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609.
10. KANETO, H., SHARMA, A., SUZUMA, K., LAYBUTT, D.R., XU, G., BONNER-WEIR, S., and WEIR, G.C. (2002). Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation. J. Biol. Chem. 277, 12998-13006.
11. LEE, J.E., HOLLENBERG, S.M., SNIDER, L., TURNER, D.L., LIPNICK, N., and WEINTRAUB, H. (1995). Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268, 836-844.
12. MATSUI, H., TOMIZAWA, K., LU, Y.F., and MATSUSHITA, M. (2003). In vivo protein transduction by polyarginine (11R). PTD and subcellular targeting delivery. Curr. Protein Pept. Sci. 4, 151-157.
13. MATSUSHITA, M., TOMIZAWA, K., MORIWAKI, A., LI, S.T., TERADA, H., and MATSUI, H. (2001). A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J. Neurosci. 21, 6000-6007.
14. NAYA, F.J., STELLRECHT, C.M., and TSAI, M.J. (1995). Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 9, 1009-1019.
15. NAYA, F.J., HUANG, H.P., QIU, Y., MUTOH, H., DEMAYO, F.J., LEITER, A.B., and TSAI, M.J. (1997). Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11, 2323-2334.
16. NOGUCHI, H., and MATSUMOTO, S. (2006). Protein transduction technology offers a novel therapeutic approach for diabetes. J. Hepatobiliary Pancreat. Surg. 13, 306-313.
17. NOGUCHI, H., KANETO, H., WEIR, G.C., and BONNER-WEIR, S. (2003). PDX-1 protein containing its own Antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52, 1732-1737.
18. NOGUCHI, H., MATSUSHITA, M., OKITSU, T., MORIWAKI, A., TOMIZAWA, K., KANG, S., LI, S.T., KOBAYASHI, N., MATSUMOTO, S., TANAKA, K., TANAKA, N., and MATSUI, H. (2004). A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. 10, 305-309.
19. NOGUCHI, H., BONNER-WEIR, S., WEI, F.Y., MATSUSHITA, M., and MATSUMOTO, S. (2005a). BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 54, 2859-2866.
20. NOGUCHI, H., NAKAI, Y., MATSUMOTO, S., KAWAGUCHI, M., UEDA, M., OKITSU, T., IWANAGA, Y., YONEKAWA, Y., NAGATA, H., MINAMI, K., MASUI, Y., FUTAKI, S., and TANAKA, K. (2005b). Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am. J. Transplant. 5, 1848-1855.
21. NOGUCHI, H., MATSUMOTO, S., OKITSU, T., IWANAGA, Y., YONEKAWA, Y., NAGATA, H., MATSUSHITA, M., WEI, F.Y., MATSUI, H., MINAMI, K., SEINO, S., MASUI, Y., FUTAKI, S., and TANAKA, K. (2005c). PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplant. 14, 637-645.
22. NOGUCHI, H., MATSUSHITA, M., MATSUMOTO, S., LU, Y.F., MATSUI, H., and BONNER-WEIR, S. (2005d). Mechanism of PDX-1 protein transduction. Biochem. Biophys. Res. Commun. 332, 68-74.
23. OHNEDA, K., MIRMIRA, R.G., WANG, J., JOHNSON, J.D., and GERMAN, M.S. (2000). The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol. Cell. Biol. 20, 900-911.
24. OLSON, E.N., and KLEIN, W.H. (1994). bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
25. ROSTAND, K.S., and ESKO, J.D. (1997). Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1-8.
26. RUSNATI, M., TULIPANO, G., URBINATI, C., TANGHETTI, E., GIULIANI, R., GIACCA, M., CIOMEI, M., CORALLINI, A., and PRESTA, M. (1998). The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J. Biol. Chem. 273, 16027-16037.
27. SCHWARZE, S.R., HO, A., VOCERO-AKBANI, A., and DOWDY, S.F. (1999). In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
28. SUMMERFORD, C., and SAMULSKI, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
29. TYAGI, M., RUSNATI, M., PRESTA, M., and GIACCA, M. (2001). Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261.
30. WADIA, J.S., STAN, R.V., and DOWDY, S.F. (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315.
31. YANAGISHITA, M., and HASCALL, V.C. (1992). Cell surface heparan sulfate proteoglycans. J. Biol. Chem. 267, 9451-9454.